Professor of Pharmacy Practice, University of East Anglia, Norwich Research Park, Norwich, UK
Though commonplace in other countries, pharmacogenomic testing is yet to become a mainstay of NHS healthcare. Here, David Wright and Dhiren Bhatt argue how this process could improve the chance of therapeutic success and why pharmacists should be at the heart of its implementation.
Demonstrating the patient benefit and value for the NHS of community pharmacy: insight from the Community Pharmacy Future modelSubscription
In the face of funding and efficiency cuts to community pharmacy, the role of the sector is coming under increasing pressure. The importance of outcomes evidence (particularly health economic evidence) is being brought sharply into focus. The profession must come together to produce the evidence needed to justify the services provided by community pharmacy and to support its future development. This article uses the Community Pharmacy Future (CPF) project, and the services developed and evalu
It is estimated that in the UK there are more than half a million people with clinically undiagnosed coeliac disease, caused by an adverse immune response to gluten, a protein found in wheat, barley and rye. Pharmacists and healthcare professionals can play a key role in identifying individuals with symptoms, referring them for testing, ultimately leading to earlier diagnosis.